Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD Patients

• Status: Completed
• Trial end date: 2015-11-01
• Target enrollment: 0
• Participant gender: All

Summary

This study compared the correct use of and patient preference for two drug delivery systems (inhalers) in patients with COPD

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novartis Pharmaceuticals
• Treatments: Tiotropium Bromide

Criteria

Key Inclusion Criteria:

1. Male and female adults aged ≥40 years, who have signed an Informed Consent form prior to initiation of any study-related procedure.

2. Co-operative outpatients with a diagnosis of moderate COPD as classified by the GOLD Guidelines 2010 or grade A in GOLD 2011and including:

• Smoking history of at least 10 pack years

• FEV1/FVC < 70%

Key Exclusion criteria:

1. Previous diagnosis of asthma

2. Pregnant or nursing women

3. Hospitalization or emergency room attendance due to COPD exacerbation within 3 months prior to visit 1